Gibson C M, Cannon C P, Greene R M, Sequeira R F, Margorien R D, Leya F, Diver D J, Baim D S, Braunwald E
Department of Medicine, the Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Am J Cardiol. 1997 Jul 1;80(1):21-6. doi: 10.1016/s0002-9149(97)00277-4.
Rescue percutaneous transluminal coronary angioplasty (PTCA) has been used to establish reperfusion after failed thrombolysis, and the goal of this study was to examine the angiographic and clinical outcomes after rescue PTCA performed for an occluded artery 90 minutes after thrombolysis. Four hundred two patients with acute myocardial infarction were randomized to receive either anistreplase (APSAC), recombinant tissue plasminogen activator, or their combination in the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. The angiographic and clinical outcomes of patients with a patent artery 90 minutes after thrombolysis were compared with those of patients with an occluded artery treated in a nonrandomized fashion with either rescue or no rescue PTCA. At 90 minutes, the number of frames required to opacify standard landmarks (corrected TIMI frame count) was significantly lower (i.e., flow was faster) after successful rescue PTCA (27 +/- 11) than that in patent arteries after successful thrombolysis (39 +/- 20, p < 0.001), and the incidence of TIMI grade 3 flow was correspondingly higher after successful rescue PTCA (87% vs 65%, p = 0.002). In-hospital adverse outcomes (death, recurrent acute myocardial infarction, severe congestive heart failure, cardiogenic shock or an ejection fraction <40%) occurred in 29% of successful rescue PTCAs and in 83% of failed rescue PTCAs (p = 0.01). Among all patients in whom rescue PTCA was performed (successes and failures combined), 35% of patients experienced an adverse outcome, which was the same as the 35% incidence observed in patients not undergoing rescue PTCA (p = NS) and tended to be higher than the 23% incidence observed in patients with patent arteries (p = 0.07). Although successful rescue PTCA for an occluded artery at 90 minutes results in restoration of flow that is superior to that of successful thrombolysis, the incidence of adverse events for the strategy of rescue PTCA as a whole was the same as that of undertaking no PTCA.
补救性经皮腔内冠状动脉成形术(PTCA)已被用于在溶栓失败后建立再灌注,本研究的目的是检查在溶栓90分钟后对闭塞动脉进行补救性PTCA后的血管造影和临床结果。在心肌梗死溶栓(TIMI)4试验中,402例急性心肌梗死患者被随机分配接受茴香酰化纤溶酶原链激酶激活剂复合物(APSAC)、重组组织型纤溶酶原激活剂或它们的联合治疗。将溶栓90分钟后动脉通畅的患者的血管造影和临床结果与以非随机方式接受补救性或非补救性PTCA治疗的闭塞动脉患者的结果进行比较。在90分钟时,成功进行补救性PTCA后使标准标志显影所需的帧数(校正TIMI帧数)显著更低(即血流更快)(27±11),低于成功溶栓后动脉通畅患者的帧数(39±20,p<0.001),并且成功进行补救性PTCA后TIMI 3级血流的发生率相应更高(87%对65%,p = 0.002)。住院不良结局(死亡、复发性急性心肌梗死、严重充血性心力衰竭、心源性休克或射血分数<40%)在29%的成功补救性PTCA患者和83%的失败补救性PTCA患者中出现(p = 0.01)。在所有接受补救性PTCA的患者(成功和失败合并)中,35%的患者出现不良结局,这与未接受补救性PTCA的患者中观察到的35%的发生率相同(p =无显著性差异),并且倾向于高于动脉通畅患者中观察到的23%的发生率(p = 0.07)。尽管在90分钟时对闭塞动脉成功进行补救性PTCA可使血流恢复优于成功溶栓,但作为整体的补救性PTCA策略的不良事件发生率与不进行PTCA相同。